Bristol-Myers Squibb Balance Sheet and Financial Statements
Bristol-Myers Squibb annual income statement, balance sheet and cash flow statement (last 4 periods).
Income Statement
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 48.19B $ | 48.3B $ | 45.01B $ | 46.16B $ |
| Cost of Revenue | 0 $ | 0 $ | 0 $ | 0 $ |
| Gross Profit | 0 $ | 0 $ | 0 $ | 0 $ |
| EBIT | 0 $ | 0 $ | 0 $ | 0 $ |
| Income Tax | 0 $ | 0 $ | 0 $ | 0 $ |
| Net Income | 7.05B $ | -8.95B $ | 8.03B $ | 6.33B $ |
Balance Sheet
Cash Flow Statement
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income | 7.05B $ | -8.95B $ | 8.03B $ | 6.33B $ |